Søgeresultater - David Fermin
- Showing 1 - 6 results of 6
-
1
-
2
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy af Florian Rader, Artur Oręziak, Lubna Choudhury, Sara Saberi, David Fermin, Matthew T. Wheeler, Theodore P. Abraham, Pablo García‐Pavía, Donna R. Zwas, Ahmad Masri, Anjali Owens, Sheila M. Hegde, Tim Seidler, Shawna Fox, Ganesh Balaratnam, Amy J. Sehnert, Iacopo Olivotto
Udgivet 2024Artigo -
3
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM af Milind Y. Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B. Geske, Anjali Owens, Sara Saberi, Andrew Z. Wang, Paul Cremer, Mark V. Sherrid, Neal K. Lakdawala, Albree Tower‐Rader, David Fermin, Srihari S. Naidu, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen, Zoran Popović, Milind Y. Desai, Jeffrey B. Geske, Mark V. Sherrid, Anjali Owens, Sara Saberi, Andrew Wang, Albree Tower‐Rader, David Fermin, Neal K. Lakdawala, Ahmad Masri, M. Zenker, John C. Stendahl, Matthew T. Wheeler, R. Bach, J. Orford, Suveeksha Naidu, Florian Rader, Pietro Bajona
Udgivet 2024Artigo -
4
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction af Milind Y. Desai, Anjali Owens, Kathy Wolski, Jeffrey B. Geske, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Neal K. Lakdawala, Albree Tower‐Rader, David Fermin, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Lana Mudarris, Zhiqun Gong, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen
Udgivet 2023Artigo -
5
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial af Milind Y. Desai, Yuichiro Okushi, Andrew Gaballa, Qiuqing Wang, Jeffrey B. Geske, Anjali Owens, Sara Saberi, Andrew Wang, Paul Cremer, Mark V. Sherrid, Neal K. Lakdawala, Albree Tower‐Rader, David Fermin, Srihari S. Naidu, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen, Zoran Popović, Milind Y. Desai, Ahmad Masri, M. Zenker, John C. Stendahl, M. Wheeler, R. Bach, J. Orford, F. Rader, Pietro Bajona, Milind Y. Desai
Udgivet 2024Artigo -
6
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial af Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa, Theodore P. Abraham, Ahmad Masri, Pablo García‐Pavía, Sara Saberi, Neal K. Lakdawala, Matthew T. Wheeler, Anjali Owens, Miloš Kubánek, Wojciech Wojakowski, Morten K. Jensen, Juan R. Gimeno, Jonathan Myers, Jonathan Myers, Sheila M. Hegde, Scott D. Solomon, Amy J. Sehnert, David Zhang, Wanying Li, Mondira Bhattacharya, Jay M. Edelberg, Cynthia Burstein Waldman, Steven J. Lester, Carolyn Y. Ho, Carolyn Y. Ho, Jozef Bartúnek, Jozef Bartúnek, Antoine Bondue, Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko−Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Leonardo Mejia Rincon, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Jonathan Myers, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Jozef Bartúnek, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Carolyn Y. Ho, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani
Udgivet 2020Artigo
Søgeredskaber:
Relaterede emner
Cardiology
Internal medicine
Medicine
Heart failure
Hypertrophic cardiomyopathy
Alternative medicine
Pathology
Placebo
Cardiomyopathy
Randomized controlled trial
Ventricular outflow tract
Adverse effect
Atrial fibrillation
Clinical trial
Cohort
Destination therapy
Double blind
Economic growth
Economics
Ejection fraction
Food and drug administration
Health care
Heart transplantation
Intensive care medicine
Investigational device exemption
Medicaid
Medical emergency
Natriuretic peptide
Nursing
Obstructive cardiomyopathy